Brian Price, Ph.D., CTO at Armatus Bio, Inc., has a successful track record of business development growth and product development in Chemistry Manufacturing and Controls (CMC) for therapeutic and vaccine development, toxicology and analytics. Prior to Armatus Bio, Dr. Price was Principal Consultant at Price Biologics Consulting, LLC, assisting in the development of scalable and efficient CMC processes for gene therapy products, and supported the development of an AAV-based COVID vaccine candidate in a COO role for Albamunity, Inc. Prior to that, he served as VP of Pharmaceutical Development at Myonexus Therapeutics until its acquisition by Sarepta in 2019. Dr. Price also served as COO at Blue Water Vaccines where he participated in the development of a universal influenza vaccine candidate. He previously held a range of leadership roles over the course of a 15-year tenure at Battelle Memorial Institute, most recently as the acting lead for business development in the Health business unit.

Earlier in his career, Dr. Price served as a technical consultant for the Joint Vaccine Acquisition Program at the Department of Defense (through the Camber Corporation) and Manager of QC at BioPort Corporation (now Emergent BioSolutions). He earned a B.S. and Ph.D. in Microbiology from The Ohio State University.